|
Video: Compound Annual Growth Rate (CAGR) Definition
|
|
Date |
Open |
High |
Low |
Close |
Volume |
11/30/2018 |
$0.72 |
$0.74 |
$0.70 |
$0.73 |
97.80K | 12/03/2018 |
$0.74 |
$0.74 |
$0.71 |
$0.73 |
271.60K | 12/04/2018 |
$0.73 |
$0.78 |
$0.73 |
$0.75 |
414.10K | 12/06/2018 |
$0.75 |
$0.84 |
$0.73 |
$0.74 |
629.90K | 12/07/2018 |
$0.73 |
$0.77 |
$0.69 |
$0.69 |
103.80K |
|
Millendo Therapeutics is a fertility company, engaged in developing proprietary treatments for female infertility based on scientific discoveries about the existence of egg precursor, or EggPCsm, cells. EggPC cells are undifferentiated germ cells from fetal development that may have the capacity to mature into eggs. Co.'s portfolio of treatment options uses its patented technology, including proprietary methods to isolate EggPC cells from a woman's own ovarian tissue. Co.'s other treatment include: OvaPrime, which is a fertility treatment that could help restore a woman's egg production; and OvaTuresm, which is a potential fertility treatment that eliminates the need for hormone stimulation. | |
|
OVAS (OVAS) has the following price history information. Looking back at OVAS historical stock prices for the last five trading days, on November 30, 2018, OVAS opened at $0.72, traded as high as $0.74 and as low as $0.70, and closed at $0.73. Trading volume was a total of 97.80K shares. On December 03, 2018, OVAS opened at $0.74, traded as high as $0.74 and as low as $0.71, and closed at $0.73. Trading volume was a total of 271.60K shares. On December 04, 2018, OVAS opened at $0.73, traded as high as $0.78 and as low as $0.73, and closed at $0.75. Trading volume was a total of 414.10K shares. On December 06, 2018, OVAS opened at $0.75, traded as high as $0.84 and as low as $0.73, and closed at $0.74. Trading volume was a total of 629.90K shares. On December 07, 2018, OVAS opened at $0.73, traded as high as $0.77 and as low as $0.69, and closed at $0.69. Trading volume was a total of 103.80K shares.
OVAS Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into OVAS shares, starting with a $10,000 purchase of OVAS, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
04/29/2014 |
|
End date: |
12/07/2018 |
|
Start price/share: |
$8.29 |
|
End price/share: |
$0.69 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-91.64% |
|
Average Annual Total Return: |
-41.62% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$836.09 |
|
Years: |
4.61 |
|
|
|
Date |
Close |
11/30/2018 | $0.73 | 12/03/2018 | $0.73 | 12/04/2018 | $0.75 | 12/06/2018 | $0.74 | 12/07/2018 | $0.69 |
|
|